ERBB2 and breast carcinoma: It has been shown that in breast cancer cells, aberrant activation of LIN28 not only represses let-7 to enable it to function as an oncogene but also promotes and maintains the proliferation of breast cancer cells by directly or indirectly stimulating the expression of tumor growth-related genes (including HER2 and HMGA1) after transcription (16, 100).